Drug Type CAR-T |
Synonyms CARTPSMATGFbRdn, CARTPSMATGFbetaRDN Cells, CARTPSMATGFbetaRdn + [2] |
Target |
Mechanism PSMA inhibitors(Prostate-specific membrane antigen inhibitors), TGF-β inhibitors(Transforming growth factor beta inhibitors), Gene transference + [1] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization Tmunity Therapeutics, Inc.Startup |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Phase 1 | US | Tmunity Therapeutics, Inc.Startup | 06 Mar 2017 |